TAIWAN · TWSE / TPEx
TWB
台寶生醫 · 6892 · Emerging Stock Board · Biotech and medical
Share price, 2026-10-19NT$26.201 month +0.0% · 1 year -6.6%
Directors and supervisors hold7,984,6638.5% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold16,390,90117.4% of shares issued
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 郭旭崧 | Chairman | — | 0 | — | — | — |
| 楊世欽 | Director | 376,056 | 571,496 | 0.61% | — | 600,113 |
| 福又達生物科技股份有限公司 | Director · Major shareholder (10%+) | 7,413,167 | 7,413,167 | 7.89% | — | — |
| 蔡佩珊 | Director (corporate representative) | — | 954,714 | 1.02% | — | 2,081,108 |
| 陳春葉 | Independent director | — | 0 | — | — | — |
| 劉景洪 | Independent director | — | 0 | — | — | — |
| 吳烈澄 | Independent director | — | 0 | — | — | — |
| 楊鈞堯 | President | — | 2,263,893 | 2.41% | — | 40,000 |
| 鄧振銘 | Assistant vice president | — | 116,626 | 0.12% | — | — |
| 吳芳儒 | Assistant vice president | — | 148,627 | 0.16% | — | — |
| 陸明山 | Assistant vice president | — | 30,000 | 0.03% | — | — |
| 宋啟華 | Assistant vice president | — | 0 | — | — | — |
| 富聿資本股份有限公司 | Major shareholder (10%+) | — | 8,977,734 | 9.55% | — | — |
| 莊秀娟 | Chief financial officer · Chief accountant | — | 200,000 | 0.21% | — | — |
Dividends
No cash dividend in the last five years.
Cash dividends by ex-dividend date and the payout ratio (dividends ÷ 12-month earnings per share) from Yahoo Finance; stock dividends and the latest decision from the Taiwan Stock Exchange; the next ex-dividend date from the exchanges' calendars, else Yahoo. Dividends do not enter any score.